Differential expression of angiotensin receptors in human cutaneous wound healing. 2005

U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
Centre for Cardiovascular Research, Institute for Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Hessische Strasse 3-4, 10115 Berlin, Germany. ulrike.steckelings@charite.de

BACKGROUND Angiotensin AT1 and AT2 receptors are expressed in human skin. Furthermore, AT2 receptors have been reported to be upregulated during tissue repair and remodelling in various noncutaneous human tissues. OBJECTIVE Detection of alterations in angiotensin II receptor expression during wound healing in human skin. METHODS Three models were employed. (i) Primary human keratinocytes were razor scraped in culture flasks and alterations in the expression of angiotensin receptor mRNA determined by semiquantitative reverse transcription-polymerase chain reaction for 1-12 h thereafter. (ii) Early wound healing (48 h after cutting) was studied in punch biopsies from human skin ex vivo by means of immunohistochemical staining using polyclonal antibodies against the AT1 or AT2 receptor. (iii) In vivo wound healing was studied in sections of human cutaneous scars by immunohistochemistry to determine receptor expression early (2 days) and late (2 weeks-3 months) after surgery. RESULTS In all experimental settings, an upregulation of both receptor subtypes was noticed after wounding. Immunohistochemically stained skin sections showed a stronger expression of AT2 than of AT1 receptors within the area of scarring. Enhanced receptor expression was detectable as early as 24 h after injury and lasted for up to 3 months. CONCLUSIONS From these data, we conclude that angiotensin AT1 and AT2 receptors are upregulated in human cutaneous wounds, giving further support to the concept that angiotensin II plays a role even at an early stage during cutaneous wound healing.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
August 2005, Gastroenterology,
U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
January 2018, Handbook of experimental pharmacology,
U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
January 1992, Peptides,
U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
February 2007, Journal of translational medicine,
U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
January 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,
U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
January 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,
U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
September 1999, The New England journal of medicine,
U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
January 2007, Journal of burn care & research : official publication of the American Burn Association,
U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
January 2004, Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina,
U M Steckelings, and B M Henz, and S Wiehstutz, and T Unger, and M Artuc
September 1992, Biochemical and biophysical research communications,
Copied contents to your clipboard!